a short-term , double-blind , placebo-controlled crossover study was completed in 15 patients with classical or definite rheumatoid arthritis to compare the antirheumatic activity of salsalate ( 3 g/day ) with placebo and indomethacin ( 75 mg/day ) .
C0003873
rheumatoid arthritis
C0021246
indomethacin